AN2 Therapeutics, Inc.'s total assets for Q3 2024 were $97.69M, a decrease of -9.95% from the previous quarter. ANTX total liabilities were $10.02M for the fiscal quarter, a -1.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.